Reuters logo
BRIEF-Bayer files for Japanese approval of extended half-life Hemophilia A compound
October 17, 2017 / 7:17 AM / 2 months ago

BRIEF-Bayer files for Japanese approval of extended half-life Hemophilia A compound

Oct 17 (Reuters) - Bayer AG

* Submits its extended half-life Hemophilia A compound for marketing authorization in Japan​

* Says ‍pivotal studies with BAY94-9027 showed that bleed protection was achieved with extended dosing intervals​ Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below